Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

Overview of attention for article published in Leukemia & Lymphoma, September 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

patent: 10 patents

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

Antiviral vaccines using spherical nucleic acids

Grant US-12691166-B2

United States of America

28 Jul 2026

Sequence multiplicity within spherical nucleic acids

Grant US-12378560-B2

United States of America

05 Aug 2025

NANOPARTICULATE FORMULATION

Application WO-2024137455-A1

World Intellectual Property Organisation (WIPO)

27 Jun 2024

PROSTATE-ASSOCIATED ANTIGENS AND VACCINE-BASED IMMUNOTHERAPY REGIMENS

Application EP-3563865-A2

European Patent Office

06 Nov 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.